Filing Details
- Accession Number:
- 0001179110-14-011221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-02 13:44:05
- Reporting Period:
- 2014-06-30
- Filing Date:
- 2014-07-02
- Accepted Time:
- 2014-07-02 13:44:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-06-30 | 10,400 | $83.98 | 46,774 | No | 4 | S | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by Trust |
Footnotes
- The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Sale prices reported for the transactions reported here range from $83.76 to $84.30. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.